Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 181 clinical trials
featured
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension

A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension

  • 106 views
  • 08 Dec, 2020
  • 1 location
Blood Pressure Control Target in Diabetes

treatment strategy (a systolic blood pressure target of <120 mmHg) is more effective than a standard treatment strategy (a systolic blood pressure target of <140 mmHg) in reducing the risk of major

  • 0 views
  • 24 Jan, 2021
  • 1 location
Outcome in Patients Treated With Intraarterial Thrombectomy - optiMAL Blood Pressure Control (OPTIMAL-BP)

> Therefore, this study will compare the effectiveness of active blood pressure control group (with less than 140 mmHg systolic blood pressure) versus standard blood pressure control group (with less than 180

hypertension
thrombectomy
arterial occlusion
intracerebral hemorrhage
cerebral infarction
  • 0 views
  • 25 Jan, 2021
  • 1 location
Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms

Purpose of this study is to assess the hypothesis that a strategy with acetylsalicylic acid (ASA) 100 mg/day, intensive blood pressure treatment (targeted systolic blood pressure below 120 mmHg

  • 0 views
  • 22 Jan, 2021
  • 12 locations
China Antihypertensive Trial in Acute Ischemic Stroke II

average systolic blood pressure (BP) between 140-200 mmHg at randomization. Patients with extracranial or intracranial artery stenosis (70%) in both sides or the affected side, NIH Stroke Scale score of

  • 0 views
  • 27 Jan, 2021
  • 1 location
REACH- Reducing Risk With E-based Support for Adherence to Lifestyle Change in Hypertension

This randomized controlled trial will evaluate whether preventive e-Counseling (Heart and Stroke Foundation Action Plan, HSF-AP; http://ww2.heartandstroke.ca/hs_bp2.asp?media=bp) improves blood pressure and lifestyle adherence among subjects diagnosed with Stage 1 or 2 hypertension. Primary hypotheses. 1. e-Counseling (vs. Control) will significantly reduce SBP, DBP and pulse pressure (PP) at the 4-, …

stroke
  • 239 views
  • 07 Nov, 2020
  • 3 locations
Effect of Lacidipine and Losartan on 24 Hour Systolic Blood Pressure Variability in Elderly Hypertensive Patients

The aim of this study is to evaluate the effect of lacidipine and losartan in elderly hypertensive patients on reducing the 24 hour systolic BP variability, which is one of the potential parameter to consider in treating elderly hypertensive patients.

systolic blood pressure
losartan
essential hypertension
  • 4 views
  • 07 Nov, 2020
  • 1 location
Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies

The purpose of this study was to determine the efficacy and safety of clevidipine for treating Hypertensive emergenciesdefined as systolic blood pressure >180 mmHg and/or diastolic blood

  • 0 views
  • 27 Jan, 2021
  • 2 locations
Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension

To evaluate the efficacy of a 4-week fludrocortisone (FLU) treatment on systolic blood pressure depression after 5 minutes of active orthostatism in patients with neurogenic orthostatic

  • 0 views
  • 24 Jan, 2021
  • 1 location
Limb Occlusion Pressure Tourniquets to Decrease Pain After Surgery

operative pain. Limb Occlusion Pressure, LOP, is based off the patient's systolic blood pressure plus a safety margin and is typically much lower than standard tourniquet pressure. The aim of this study is

  • 0 views
  • 24 Jan, 2021